The Notch signaling pathway is one of the most fundamental communication systems cells use to coordinate with their neighbors, governing everything from how an embryo takes shape to how adult tissues repair themselves. It works through direct physical contact between cells: a signal-sending cell displays a ligand protein on its surface, and the neighboring cell’s Notch receptor grabs onto it, triggering a chain of molecular events that ultimately changes which genes get switched on. Because this pathway touches so many processes, defects in Notch signaling are implicated in cancers, inherited disorders, and degenerative diseases. What makes the pathway particularly fascinating is that the same core machinery can drive wildly different outcomes depending on the tissue and timing involved.
How the Signal Fires
Notch signaling is unusual among cell communication systems because it requires the signal-sending and signal-receiving cells to be in direct contact. The receptor (called Notch, of which mammals have four versions, Notch1 through Notch4) sits on the surface of one cell, while ligands from the Delta and Jagged families sit on the neighboring cell. When a ligand binds the receptor, the signal-sending cell actually pulls on it. Using an optical-tweezers system to measure forces between individual cells and beads, researchers found that ligand-expressing cells exert a pulling force of roughly 10 piconewtons on the Notch receptor, a tug generated by the cell drawing the bound ligand back inside itself through endocytosis.1PubMed Central. Notch ligand endocytosis generates mechanical pulling force dependent on dynamin, epsins, and actin That mechanical yank is not incidental. It physically peels open a protected region of the Notch receptor, exposing it to a sequence of cuts by enzymes.
Three sequential cleavage events control Notch activation.2PubMed Central. Proteolytic cleavage of Notch: “HIT and RUN” The first happens during receptor manufacturing, before the receptor even reaches the cell surface. The second is triggered by the ligand’s pull and is carried out by a metalloprotease that snips the extracellular portion. The third, and arguably most consequential, cut is performed by a protein complex called gamma-secretase, which slices the receptor inside the cell membrane itself. This final cut releases a fragment called the Notch intracellular domain, which travels into the nucleus, pairs up with a transcription factor called RBPJ along with co-activators, and switches on target genes.3PubMed Central. Notch-dependent and -independent functions of transcription factor RBPJ When the intracellular domain is absent, RBPJ does not just sit idle; it actively teams up with co-repressors to keep those same genes silent.4PubMed Central. Structural and Functional Studies of the RBPJ-SHARP Complex Reveal a Conserved Corepressor Binding Site The pathway thus functions like a sharp binary switch: signal off means active repression, signal on means active gene expression.
How Cells Tune the Volume
If Notch signaling were a simple on/off switch with no dials, it could not produce the enormous variety of outcomes seen across different tissues. One key set of volume controls comes from a family of enzymes called Fringe glycosyltransferases. These enzymes add sugar molecules to the Notch receptor before it reaches the cell surface, and the type of sugar decoration changes how the receptor responds to different ligands. In mammalian cells, Lunatic Fringe and Manic Fringe boost the receptor’s responsiveness to Delta-family ligands while dampening its response to Jagged1. Radical Fringe, by contrast, enhances signaling from both Delta and Jagged ligands.5PubMed Central. Fringe glycosyltransferases differentially modulate Notch1 proteolysis induced by Delta1 and Jagged1 The presence and type of these sugar modifications on the receptor dictate which ligands it listens to and which it ignores.6PubMed. Modulation of notch-ligand binding by protein O-fucosyltransferase 1 and fringe
Cells can also use Notch signaling outside the standard playbook. In what researchers call non-canonical Notch signaling, the intracellular domain can trigger gene changes without relying on the RBPJ transcription factor at all. One study in breast tumor cells found that a non-canonical route activated inflammatory signaling through the IL-6/JAK/STAT pathway, and this activation could be driven by a version of the intracellular domain that was stuck in the cytoplasm, never entering the nucleus the way the canonical pathway requires.7PubMed Central. Non-canonical Notch signaling activates IL-6/JAK/STAT signaling in breast tumor cells and is controlled by p53 and IKKα/IKKβ These alternative routes add another layer of complexity and help explain why Notch does such different things in different cell types.
Sorting Cells During Embryonic Development
One of the earliest and best-understood roles of Notch is a process called lateral inhibition. When a group of initially identical precursor cells needs to split into two different fates, Notch helps them make the decision. A cell that starts expressing a bit more of a Delta ligand sends a stronger signal to its neighbors, telling them through Notch activation to adopt a different fate. Those neighbors, now receiving high Notch signaling, are steered away from the fate the Delta-expressing cell is taking. The result is a “salt and pepper” pattern of alternating cell types arising from what was a uniform population.8PubMed Central. Notch-mediated lateral inhibition regulates proneural wave propagation when combined with EGF-mediated reaction diffusion
This mechanism is particularly important in the nervous system. In the developing zebrafish spinal cord, newly specified neurons express Delta proteins that activate Notch in their neighboring cells. That Notch signal keeps those neighbors in a proliferative precursor state, preventing them from differentiating into neurons at the same time. This coordination ensures the embryo does not burn through its neural precursors too quickly and can still generate later-born neurons and supporting glia cells.9PubMed. Delta-Notch signaling and lateral inhibition in zebrafish spinal cord development
The Segmentation Clock
Notch has a particularly striking role in somitogenesis, the process by which the embryo forms the repeating segments that eventually give rise to vertebrae, ribs, and skeletal muscles. Cells in the presomitic mesoderm do not differentiate in one steady wave. Instead, they oscillate, with certain genes cycling on and off rhythmically. In zebrafish, the genes her1 and her7 oscillate through negative feedback loops, and their activity drives oscillating expression of the Notch ligand DeltaC. In mice, the analogous gene Hes7 drives oscillating expression of the Notch modifier Lunatic Fringe. Notch signaling synchronizes these oscillations between neighboring cells, ensuring each segment forms as a coherent unit rather than a mess of out-of-phase cells.10PubMed. The Notch Signalling Pathway in Development and Disease In human mesenchymal stem cell models, the cycling gene HES1 oscillates with roughly a five-hour period, consistent with the slower pace at which human embryos form segments compared with mice, where the cycle runs at about two hours.11PubMed Central. Identification of oscillatory genes in somitogenesis from functional genomic analysis of a human mesenchymal stem cell model
Building Blood Vessels
When new blood vessels sprout from existing ones, a process called angiogenesis, the cells at the growing tip face a leadership contest. “Tip cells” lead the sprout forward, extending probing filaments into the tissue, while “stalk cells” follow behind, proliferating to extend the vessel. Notch and VEGF signaling work together to sort out who leads and who follows. A cell that receives a strong VEGF signal upregulates Delta-like 4, which activates Notch in its neighbors, suppressing their tip-cell behavior and pushing them into the stalk-cell role.12PubMed Central. VEGF and Notch in tip and stalk cell selection The interplay between these two pathways ensures that vessels grow in an orderly, branched pattern rather than forming disorganized clumps.
Notch and the Immune System
T cells, the immune system’s key players in fighting infections and cancer, owe their existence to Notch signaling. When blood-forming progenitor cells arrive in the thymus, Notch acts as the initial trigger that commits them toward becoming T cells rather than other blood cell types.13PubMed Central. Eliciting the T cell fate with Notch Without Notch signals, those same progenitors would default to other lineages. After thymic entry, continued Notch signaling is required to specify and reinforce the T cell identity from what starts as a multipotent progenitor.14PubMed. Notch regulation of early thymocyte development This makes Notch essential not just for building organs during embryonic life but for maintaining the immune system throughout adulthood.
Maintaining Adult Tissues
Notch continues to work long after development is complete. In the gut, it directs the fate of stem cell descendants that constantly replace the intestinal lining. When Notch is active in intestinal progenitor cells, it steers them toward becoming absorptive cells, the type that take up nutrients. It does this by blocking the program for secretory cell differentiation. When researchers knocked out Notch signaling in mice, the intestinal lining was overrun by secretory cells like goblet cells. When they did the opposite, switching Notch on permanently, secretory cell types virtually disappeared.15PubMed Central. Notch regulation of gastrointestinal stem cells
In the brain, Notch plays a different but equally critical role: keeping neural stem cells in a quiet, resting state known as quiescence. In the fruit fly, Notch activity promotes neuroblast quiescence, and reducing Notch levels triggers these dormant cells to re-enter the cell cycle and start dividing again, a process normally coupled to nutritional cues.16PubMed Central. Notch signaling regulates neural stem cell quiescence entry and exit in Drosophila In the adult mouse brain, inactivating Notch signaling caused slowly dividing neural stem cells to prematurely convert into rapidly proliferating transit-amplifying cells, depleting the stem cell reserve within days.17Journal of Neuroscience. Essential Roles of Notch Signaling in Maintenance of Neural Stem Cells in Developing and Adult Brains Without Notch acting as a brake, the brain burns through its regenerative capacity.
Cancer and the Dual Nature of Notch
Perhaps the most surprising feature of Notch in disease is that it can act as both a cancer driver and a cancer suppressor, depending on the tissue. In T cell acute lymphoblastic leukemia (T-ALL), Notch1 is one of the most commonly mutated genes. Gain-of-function mutations that lock Notch1 into a permanently active state were found in more than half of T-ALL cases, spanning all major molecular subtypes of the disease.18PubMed. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia These activating mutations have also been linked to therapeutic resistance, making the leukemia harder to treat.19PubMed Central. NOTCH1 signaling promotes human T-cell acute lymphoblastic leukemia initiating cell regeneration in supportive niches
In solid tumors, Notch can also promote cancer aggressiveness. Under low-oxygen conditions common inside tumors, Notch signaling helps cancer cells undergo epithelial-mesenchymal transition, a process where cells become more mobile and invasive. Blocking Notch in these settings stopped the transition, while artificially activating it could substitute for the low-oxygen trigger entirely.20PubMed Central. Notch signaling mediates hypoxia-induced tumor cell migration and invasion In breast cancer, silencing Notch1 reversed the invasive transition and inhibited the growth of xenograft tumors in mice.21PubMed Central. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner
Yet in squamous cell carcinomas, the picture flips. Researchers identified loss-of-function mutations in Notch1 or Notch2 in about three-quarters of cutaneous squamous cell carcinomas and in a smaller fraction of lung squamous cell carcinomas.22PubMed Central. Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma Rather than being overactive, Notch is broken in these cancers. Mouse experiments confirmed that when Notch signaling is lost in squamous epithelium, the tissue becomes prone to hyperplasia and increased tumor formation, partly through creating a wound-like inflammatory environment in the surrounding tissue.23PubMed. Notch signaling in oral squamous neoplasia The accumulating evidence across skin, oral, esophageal, and lung squamous cancers points to Notch functioning as a tumor suppressor in these tissues.24PubMed Central. Does Notch play a tumor suppressor role across diverse squamous cell carcinomas? This dual identity is a serious practical concern: therapies designed to block Notch to treat one cancer could, in theory, promote another.
Inherited Diseases Caused by Notch Mutations
Several inherited disorders trace directly back to defects in Notch pathway components. CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) is caused by mutations in the NOTCH3 gene. It is the most common hereditary cause of stroke and vascular dementia, typically striking in mid-adulthood. The mutations were first identified in the mid-1990s and disrupt the Notch3 receptor, which is heavily expressed in the smooth muscle cells lining small arteries in the brain.25PubMed. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia CADASIL mutations typically affect a specific structural region of the receptor’s extracellular domain.26PubMed Central. NOTCH3 and CADASIL syndrome: a genetic and structural overview
Alagille syndrome is another inherited disorder driven by Notch pathway defects. It is a multisystem condition most visibly affecting the liver, heart, skeleton, eyes, and face. Most cases are caused by mutations in JAG1, the gene for the Notch ligand Jagged1. But in patients who test negative for JAG1 mutations, researchers found that mutations in NOTCH2 can produce a similar syndrome.27PubMed Central. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway These NOTCH2 mutations, identified across both the extracellular and intracellular portions of the receptor, abolished Notch signaling in cell-based assays. Interestingly, patients with NOTCH2 mutations had some clinical differences: liver disease was universal, but skeletal anomalies and the characteristic facial features were less common than in patients with JAG1 mutations.28PubMed Central. NOTCH2 mutations in Alagille syndrome Alagille syndrome is inherited in an autosomal dominant pattern, meaning a single faulty copy of JAG1 or NOTCH2 can cause disease.29Journal of Clinical and Translational Hepatology. Clinical and Genetic Characteristics of Alagille Syndrome in Adults
The Difficulty of Targeting Notch Therapeutically
Given how deeply Notch is involved in cancer, it has been an obvious drug target. One early strategy involved blocking gamma-secretase, the enzyme that performs the final critical cut releasing the intracellular domain. But gamma-secretase inhibitors have run into a persistent problem: because Notch signaling is essential for intestinal homeostasis, blocking it system-wide causes gut inflammation, essentially the same secretory cell overproduction seen in genetic knockout experiments.30PubMed. Pharmacological inhibitors of the gamma-secretase enzyme complex disrupt epithelial cell function triggering colitis in mice Clinical trials for both cancer and Alzheimer’s disease (where gamma-secretase processes a different substrate) have been hampered by this gastrointestinal toxicity.
More targeted approaches are in development. Monoclonal antibodies designed to bind specific regions of the Notch1 receptor can block ligand binding in a dose-dependent manner, inhibiting signaling from both Jagged1 and Delta-like 4. In preclinical breast cancer models, these antibodies depleted populations of cells thought to behave like cancer stem cells.31Molecular Cancer Therapeutics. A Monoclonal Antibody against Human Notch1 Ligand–Binding Domain Depletes Subpopulation of Putative Breast Cancer Stem–like Cells The hope is that antibodies targeting specific Notch receptors or ligands can avoid the broad toxicity of gamma-secretase inhibitors, though clinical data remain limited. The dual role of Notch as both oncogene and tumor suppressor adds further complication: you would not want to block a pathway in the skin that is actually preventing squamous cell carcinoma there.
Crosstalk with Other Signaling Pathways
Notch does not work in isolation. It constantly interacts with other major cell signaling pathways, and the outcome of those interactions can determine whether a cell proliferates, differentiates, or stays quiescent. A well-characterized example occurs in muscle stem cells during tissue repair. After injury, Notch signaling initially drives muscle precursor cells to expand in number. Then a temporal switch occurs: Wnt signaling ramps up and overrides Notch, pushing cells from proliferation into differentiation to actually form new muscle fibers. The handoff between the two pathways happens through a shared molecular intermediary, and disrupting the timing of this switch impairs normal muscle regeneration.32PubMed. A temporal switch from notch to Wnt signaling in muscle stem cells is necessary for normal adult myogenesis
In the mammary gland, the interplay between Wnt and Notch takes a different form. A chromatin-regulating protein called Pygo2, which acts downstream of Wnt signaling, directly keeps the Notch3 gene in a repressed state in mammary stem and basal cells. This Wnt-mediated silencing of Notch3 restricts those cells from differentiating into certain luminal cell types, maintaining their stem-like properties.33PubMed Central. Chromatin effector Pygo2 mediates Wnt-notch crosstalk to suppress luminal/alveolar potential of mammary stem and basal cells These examples illustrate that the effect of Notch signaling on any given cell is not determined by Notch alone but by the constellation of other signals the cell is simultaneously receiving.
An Ancient Pathway
Notch signaling is not a recent evolutionary invention. A comparative genomic analysis searching for Notch pathway components across 35 species spanning eight major branches of eukaryotic life confirmed that true Notch receptors and their Delta/Jagged ligands are specific to animals (Metazoa), but many of the protein domains and downstream components have much deeper evolutionary roots. Some pathway members appear to have been assembled by shuffling pre-existing protein building blocks, while others may trace to horizontal gene transfer events early in eukaryotic evolution.34BioMed Central / PubMed Central. Origin and evolution of the Notch signalling pathway: an overview from eukaryotic genomes The pathway’s conservation across insects, fish, and mammals underscores why discoveries in fruit flies and zebrafish translate so readily to understanding human disease. It also means that when Notch goes wrong, the consequences tend to be severe: evolution does not preserve a signaling system this tightly across hundreds of millions of years unless it is doing something indispensable.